Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Axfood AB | Stockholm | Consumer Non-Cyclicals | Food & Drug Retailing | SEK 50.53B | 23.1x | -3.35 | SEK 234.20 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.4% Upside | Upgrade to Pro+ | |
Viva Wine AB | Stockholm | Consumer Non-Cyclicals | Food & Drug Retailing | SEK 3.41B | 30.9x | -1.29 | SEK 38.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.8% Upside | Upgrade to Pro+ | |
EQL Pharma | Stockholm | Consumer Non-Cyclicals | Food & Drug Retailing | SEK 2.38B | 69.1x | 4.94 | SEK 82 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5.5% Downside | Upgrade to Pro+ | |
AcuCort | Spotlight | Consumer Non-Cyclicals | Food & Drug Retailing | SEK 109.16M | -6.4x | -0.12 | SEK 0.92 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Newbury Pharmaceuticals AB | Stockholm | Consumer Non-Cyclicals | Food & Drug Retailing | SEK 82.48M | -4.9x | -0.3 | SEK 3.40 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Harm Reduction AB | Spotlight | Consumer Non-Cyclicals | Food & Drug Retailing | SEK 6.95M | -0.1x | 0 | SEK 0.02 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |